China Oncology ›› 2018, Vol. 28 ›› Issue (1): 1-10.doi: 10.19401/j.cnki.1007-3639.2018.01.001

Previous Articles     Next Articles

Recent advances in basic research, clinical diagnosis and treatment of pancreatic cancer in 2017

ZHANG Shirong, JIN Wei, LIU Liang, YU Xianjun   

  1. Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University; Shanghai Pancreatic Cancer Institute; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
  • Online:2018-01-30 Published:2018-02-07
  • Contact: YU Xianjun E-mail: yuxianjun@fudanpci.org

Abstract: Pancreatic cancer is a highly lethal disease in gastrointestinal malignant tumors. The prognosis of patients with pancreatic cancer is poor, due to the rapid progression, lack of early diagnosis, low surgical resection rate and inefficiency of chemotherapy. The incidence of pancreatic cancer has increased significantly in the recent years. As the understanding of tumor behavior deepens, the basic research navigates new routes for clinical treatment and enriches clinical methods. Pancreatic cancer treatment has been transitioned from “surgery first” to multidisciplinary collaborative treatment team (MDT) models. In this review, we summarized recent high quality studies on pancreatic cancer including epidemiological investigation, pathogenic factor, advances in basic research, and clinical treatment.

Key words: Pancreatic cancer, Epidemiology, Basic research, Clinical research, Progress